+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Toxoplasma gondii induces a T-independent IFN-c response in natural killer cell that requires both adherent accessory cells and tumor necrosis factor-a



Toxoplasma gondii induces a T-independent IFN-c response in natural killer cell that requires both adherent accessory cells and tumor necrosis factor-a



Journal of Immunology 150: 82-9




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 018188184

Download citation: RISBibTeXText


Related references

Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. Journal of Immunology 150(9): 3982-3989, 1993

Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infection and Immunity 62(7): 2818-2824, 1994

Evidence for the involvement of human natural killer cytotoxic factors but not tumor necrosis factor in the natural killer lytic mechanism natural killer resistant variants can be generated by the prolonged culture of u 937 cells in natural killer cytotoxic factors but not tumor necrosis factor. Journal of Cellular Biochemistry Supplement (10 PART B): 94, 1986

Acute toxoplasma infection of mice induces spleen natural killer cells that are cytotoxic for toxoplasma gondii in vitro. Journal of Immunology 136(1): 313-319, 1986

Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii. European Journal of Immunology 25(4): 994-1000, 1995

Suramin inhibits tumor cell cytotoxicity mediated through natural killer cells, lymphokine-activated killer cells, monocytes and tumor necrosis factor. Journal of Clinical Immunology 14(1): 39-49, 1994

Interleukin-1 alpha and tumor necrosis factor-alpha protect cells against natural killer cell-mediated cytotoxicity and natural killer cytotoxic factor. Cellular Immunology 125(2): 326-336, 1990

An important role of tumor necrosis factor receptor-2 on natural killer T cells on the development of dsRNA-enhanced Th2 cell response to inhaled allergens. Allergy 69(2): 186-198, 2014

Peripheral natural killer cell activity and intraperitoneal soluble p55 tumor necrosis factor receptor in patients with malignant ascites: two possible indicators for response to intraperitoneal combined tumor necrosis factor alpha and interferon gamma treatment. Cancer Immunology, ImmunoTherapy 42(1): 31-37, 1996

Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. Journal of Immunology 146(9): 3045-3048, 1991

Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infection and Immunity 69(12): 7889-7893, 2001

Natural killer cell-dependent apoptosis of peripheral murine hematopoietic progenitor cells in response to Fas cross-linking: involvement of tumor necrosis factor-alpha. Blood 97(10): 3069-3074, 2001

Studies on the mechanism of natural killer cell mediated cytotoxicity vii. functional comparison of human natural killer cytotoxic factor with recombinant lymphotoxin and tumor necrosis factor. Journal of Immunology 138(6): 1791-1798, 1987

Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cells. Journal of Applied Toxicology 33(6): 503-510, 2013

Tumor necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumor necrosis factor. British Journal of Cancer 60(4): 585-588, 1989